Ohio State using high tech way to study parent child interactions
Cochlear implants have granted many children, who may have otherwise been deaf their entire life, the ability to hear. However, challenges still remain for them, as many with the implant struggle to develop language skills at the same rate as children with naturally normal hearing.
A new study at The Ohio State University Wexner Medical Center seeks to better understand how children learn words, and we are using a high-tech approach to get answers.
“Our approach is to examine how the hearing loss affects their basic, but very complex, interactions with their parents,” says Derek Houston, who is leading this research study at the Buckeye Center for Hearing and Development.
During the study, children wear eye-tracking cameras to record exactly where they focus their attention when their parent gives them a toy and says the name of that toy. This interaction is recorded using multiple camera angles.
“The timing of when a parent says a label and what the child is doing when the label is said predicts whether or not the child will learn a word,” Houston says.
Learning more about how children with cochlear implants absorb information will help parents better guide language development.
More from Ohio State
Ohio State first to use new heart failure treatment that could help millions
Heart failure patients have a new treatment option after cardiologists at The Ohio State Wexner Medical Center were the first in the U.S. to use a pulmonary neuromodulation system.
What Outpatient Care New Albany means for the future of central Ohio health care
We've turned our attention to how central Ohioans can reach their best health possible — conveniently and affordably.
Novel gene therapy offers hope for rare neurological disease
New gene therapy helps children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. Researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine say this gene therapy offers hope to those living with incurable genetic and neurodegenerative diseases.
